Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
19.21
-0.17 (-0.88%)
At close: Apr 7, 2026, 4:00 PM EDT
19.22
+0.01 (0.05%)
After-hours: Apr 7, 2026, 7:58 PM EDT
Crescent Biopharma Market Cap
Crescent Biopharma has a market cap or net worth of $638.04 million as of April 7, 2026.
Market Cap
638.04M
Enterprise Value
426.49M
1-Year Change
n/a
Ranking
Category
Stock Price
$19.21
Market Cap Chart
Since June 16, 2025, Crescent Biopharma's market cap has increased from $308.79M to $638.04M, an increase of 106.63%. That is a compound annual growth rate of 146.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 6, 2026 | 643.69M | 177.62% |
| Dec 31, 2025 | 231.86M | -24.91% |
| Jun 16, 2025 | 308.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SpyGlass Pharma | 704.30M |
| Alto Neuroscience | 682.04M |
| Lexicon Pharmaceuticals | 677.89M |
| BridgeBio Oncology Therapeutics | 672.28M |
| Gyre Therapeutics | 650.16M |
| Replimune Group | 644.07M |
| LB Pharmaceuticals | 640.07M |
| Allogene Therapeutics | 638.70M |